United States· US:70518-3829_53d3403f-783c-f424-e063-6294a90a64ac

FAMOTIDINE

A famotidine product containing famotidine, registered in United States by REMEDYREPACK INC.. The same ATC class is registered in 15 of our 19 countries.

ATC A02BA03

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedFAMOTIDINEATCA02BA03REGISTER NO.US:70518-3829_53d3403…PACKS LISTED8CHECKEDSeptember 27, 2026

Where it is registered

Famotidine is registered in 15 of 19 countries.

Countries holding a registration under ATC A02BA03 (famotidine), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 8 of them publish a price we can compare per daily dose

Famotidine · ATC A02BA03

15 / 19 countries

  • Canada
  • Czechiaprice
  • Finlandprice
  • Franceprice
  • Germany
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of famotidine costs, country by country.

Normalised to the WHO defined daily dose (40 mg), the median price runs from $0.26 in Spain to $0.76 in Italy — a ×3.0 gap.

  • 3 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Famotidine · price per daily dose (40 mg)

USD · FX 28 Sept 2026

  • IT Italy$0.76
  • FR France$0.59
  • ES Spain$0.26
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
FAMOTIDINE
Manufacturer
REMEDYREPACK INC.
Country
United States (US)
ATC code
A02BA03
ATC class
Famotidine
Defined daily dose
40 mg, O
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 8

  • ndc11
    70518-3829-1
  • ndc11
    70518-3829-3
  • ndc11
    70518-3829-6
  • ndc11
    70518-3829-7
  • ndc11
    70518-3829-9
  • ndc11
    70518-3829-4
  • ndc11
    70518-3829-5
  • ndc11
    70518-3829-8

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

778 interactions on record for famotidine.

Graded by severity as the source publishes them — 14 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Famotidine · interactions on record

778 records

  • 14 severe
  • 277 moderate
  • 52 minor
  • 434 info

Most severe, free to view

  • AtazanavirJ05AE08severe
  • RilpivirineJ05AG05severe
  • DasatinibL01EA02severe
  • NeratinibL01EH02severe

1 more interaction with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Famotidine in 13 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All famotidine products

Authorised across Europe · EMA

The same active substance is authorised in 25 EEA countries. Names it is sold under:

  • Austria · Famosin, Famotidin !$tada
  • Bulgaria · Famore 20 Mg, Famore 40 Mg
  • Cyprus · Famopsin, Ulcedine
  • Czechia · Famosan, Kuladgy
  • Germany · Famotidin Ratiopharm, Famotidin Stada
  • Estonia · Kuladgy
  • Spain · Famotidina Aristo, Famotidina Cinfa
  • Finland · Pepcid
  • France · Famotidine Eg, Famotidine Eg Labo
  • United Kingdom (Northern Ireland) · Famotidine Alissa Healthcare Research, Famotidine Celix Pharma
  • Greece · Banatin, Famotidine Beλκα Ελλασ
  • Croatia · Confamo, Famosan
  • Hungary · Apo-Famotidin, Motidin
  • Ireland · Famotidine Amdipharm, Famotidine Clonmel
  • Italy · Famotidina Doc, Famotidina Eg
  • Lithuania · Kuladgy, Quamatel
  • Latvia · Kuladgy, Quamatel
  • Malta · Famotidine Clonmel Healthcare
  • Netherlands · Famotidine Aurobindo, Famotidine Centrafarm
  • Norway · Famotidin Vivanta, Pepcid
  • Poland · Famiflux, Famogast
  • Portugal · Lasa
  • Romania · Famodin, Famotidină Zentiva
  • Sweden · Famotidin Vivanta, Pepcid
  • Slovakia · Famosan, Famotidin Sl Zentiva

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/fd4f6b16-ea17-427d-a5f1-dbbdbefda869
GET /v1/drugs/fd4f6b16-ea17-427d-a5f1-dbbdbefda869?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "20",
  "substance": "FAMOTIDINE",
  "productndc": "70518-3829",
  "dosage_form": "TABLET, FILM COATED",
  "dea_schedule": null,
  "strength_unit": "mg/1",
  "application_number": "ANDA215630",
  "marketing_category": "ANDA"
}

See everything about famotidine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.